Studies

VX21-147-301, VX-147, for APOL1

Internal Medicine Nephrology Kidney Disease Pediatric Subjects Adult Subjects

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney disease.